CS logo
small CS logo
Kasugai Municipal Hospital

Kasugai, Aichi, Japan
General hospital in Kasugai
1 Chome-1番地1 Takakicho, Kasugai, Aichi 486-8510

About Kasugai Municipal Hospital


"春日井市民病院は、名古屋北部に隣接する春日井市が管理する自治体病院として、地域の医療にかかわる要望に誠実かつ不断に応えることを存立の意義としています。24床の集中治療室や脳卒中専用の病室を設置、救命救急センターとして6床の救急外来病床を設置し、年間約1万件の救急搬送を受け入れています。 また、第二種感染症指定医療機関として 6床感染症病床を有す。その他、愛知県がん診療 拠点病院、地域医療支援病院、地域中核災害拠点病院、DMAT指定医療機関など各種指定を受け、幅広い疾患に対応する地域の基幹病院です。"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Bayer
2
Nagoya University
2
Eli Lilly and Company
1
Total Rows: 4

Clinical Trials at Kasugai Municipal Hospital


During the past decade, Kasugai Municipal Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years3300003300111100000000111100Started TrialsCompleted Trails201720182019202020212022202301234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Trial of the Irradiance Level of Phototherapy for Neonatal Jaundice
2017-07-01
2023-03-31
Recruiting
300
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
The Clinical Trial of ADR-001 for IgA Nephropathy
2020-06-15
2023-03-31
Active, not recruiting
9
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
2020-12-16
2023-08-31
Active, not recruiting
6,522
A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)
2023-02-03
2025-01-08
Recruiting
432
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Kasugai Municipal Hospital" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator and "Rohto Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 3Boehringer Ingelheim: 3Bayer: 2Bayer: 2Nagoya University: 2Nagoya University: 2Eli Lilly and Company: 1Eli Lilly and Company: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 3Eli Lilly and Company: 3Rohto PharmaceuticalCo., Ltd.: 1Rohto PharmaceuticalCo., Ltd.: 1

Clinical Trials Conditions at Kasugai Municipal Hospital


According to Clinical.Site data, the most researched conditions in "Kasugai Municipal Hospital" are "Heart Failure" (4 trials), "Atrial Fibrillation" (1 trials), "Glomerulonephritis , IGA" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Kasugai Municipal Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Kasugai Municipal Hospital


Most popular intervention types in "Kasugai Municipal Hospital" are "Drug" (6 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Empagliflozin" (3 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kasugai Municipal Hospital


The vast majority of trials in "Kasugai Municipal Hospital" are 8 trials for "All" genders.

Clinical Trials Status at Kasugai Municipal Hospital


Currently, there are NaN active trials in "Kasugai Municipal Hospital". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kasugai Municipal Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kasugai Municipal Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 3Active, not recruiting: 3Recruiting: 3Recruiting: 3Completed: 2Completed: 2